EyePoint Pharmaceuticals, Inc Earning Date (EYPT)

USA |NASDAQ |USD

EYPT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 2, 2022 Jun 2022 - - $-0.35
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 2, 2022 Jun 2022 - - $9.01M

Eyepoint Pharmaceuticals, Inc's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 2022.

EYPT Earnings Date & History Chart

EYPT Earnings & Revenue Forecast

EYPT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $-2.13 $-3.10 $-1.27

EYPT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 1 $-1.58 $-1.58 $-1.58

EYPT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $50.80M $43.80M $59.50M

EYPT Earnings Date & Revenue History

EYPT Earnings History

|
Show More
Show More

EYPT Revenue History

|
Show More
Show More

Eyepoint Pharmaceuticals, Inc Next Earnings Date & Report

EYPT Next Earnings Date & Report Preview: Jun 2022 (FQ)

EYPT's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 30, 2022.

Eyepoint Pharmaceuticals, Inc Previous Earnings Dates & Reports

EYPT Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Eyepoint Pharmaceuticals, Inc's previous earnings date was May 3, 2022 for its fiscal quarter ended Mar 31, 2022.

EYPT Previous Earnings Date & Report Recap: Dec 2021 (FY)

Eyepoint Pharmaceuticals, Inc's previous annual earnings date was Mar 3, 2022 for its fiscal year ended Dec 31, 2021.

EYPT's earnings per share (EPS) was $-2.02, missing the consensus analysts forecast of $-1.91 by 5.76% , and higher than the previous year's EPS (Dec 2020) by -41.79%.

Revenues were $36.94M, better than the forecast of $35.39M by 4.38%, and up by 7.27% from previous year's revenue.

The company reported a net income of $-58.42M.

Eyepoint Pharmaceuticals, Inc reported a free cash flow of $1.48M for its fiscal year, compared to $-14.80M a year ago.

The company ended the fiscal year with $36.56M in total debt, a decrease of -21.05% compared to the previous year.